This two-part series is hosted by Dr. Michael McClung, the Founding Director of the Oregon Osteoporosis Center in Portland and an internationally recognized clinician, researcher, and educator in osteoporosis and metabolic bone diseases. Throughout these episodes, he will speak with two pioneers in the osteoporosis treatment field, Socrates Papapoulos and Felicia Cosman.  These ASBMR members have been critical in harnessing the genetics of high bone mass disorders for their translation into a potent and now widely used anabolic therapy for osteoporosis, romozosumab. Dr. Felicia Cosman is the Professor of Clinical Medicine at Columbia University College of Physicians and Surgeons who holds a long history of being an investigator in many clinical trials exploring various strategies for the use of osteoanabolic or bone forming therapies for osteoporosis.

<description>&lt;p&gt;This two-part series is hosted by Dr. Michael McClung, the Founding Director of the Oregon Osteoporosis Center in Portland and an internationally recognized clinician, researcher, and educator in osteoporosis and metabolic bone diseases. Throughout these episodes, he will speak with two pioneers in the osteoporosis treatment field, Socrates Papapoulos and Felicia Cosman. &lt;br/&gt;&lt;br/&gt;These ASBMR members have been critical in harnessing the genetics of high bone mass disorders for their translation into a potent and now widely used anabolic therapy for osteoporosis, romozosumab.&lt;br/&gt;&lt;br/&gt;Dr. Felicia Cosman is the Professor of Clinical Medicine at Columbia University College of Physicians and Surgeons who holds a long history of being an investigator in many clinical trials exploring various strategies for the use of osteoanabolic or bone forming therapies for osteoporosis.&lt;/p&gt;</description>

This two-part series is hosted by Dr. Michael McClung, the Founding Director of the Oregon Osteoporosis Center in Portland and an internationally recognized clinician, researcher, and educator in osteoporosis and metabolic bone diseases. Throughout these episodes, he will speak with two pioneers in the osteoporosis treatment field, Socrates Papapoulos and Felicia Cosman.   These ASBMR members have been critical in harnessing the genetics of high bone mass disorders for their translation ...

Pathways: Stories of Discovery - Dr. Felicia Cosman, Columbia University

This two-part series is hosted by Dr. Michael McClung, the Founding Director of the Oregon Osteoporosis Center in Portland and an internationally recognized clinician, researcher, and educator in osteoporosis and metabolic bone diseases. Throughout these episodes, he will speak with two pioneers in the osteoporosis treatment field, Socrates Papapoulos and Felicia Cosman. These ASBMR members have been critical in harnessing the genetics of high bone mass disorders for their translation into a potent and now widely used anabolic therapy for osteoporosis, romozosumab.Dr. Socrates Popapoulus, Professor of Medicine at the Leiden University Centre for Bone Quality in the Netherlands, joins this episode to discuss his experience in the field, why paying close attention to the patient matters, and much more.

<description>&lt;p&gt;This two-part series is hosted by Dr. Michael McClung, the Founding Director of the Oregon Osteoporosis Center in Portland and an internationally recognized clinician, researcher, and educator in osteoporosis and metabolic bone diseases. Throughout these episodes, he will speak with two pioneers in the osteoporosis treatment field, Socrates Papapoulos and Felicia Cosman. &lt;/p&gt;&lt;p&gt;These ASBMR members have been critical in harnessing the genetics of high bone mass disorders for their translation into a potent and now widely used anabolic therapy for osteoporosis, romozosumab.&lt;/p&gt;&lt;p&gt;Dr. Socrates Popapoulus, Professor of Medicine at the Leiden University Centre for Bone Quality in the Netherlands, joins this episode to discuss his experience in the field, why paying close attention to the patient matters, and much more. &lt;/p&gt;</description>

This two-part series is hosted by Dr. Michael McClung, the Founding Director of the Oregon Osteoporosis Center in Portland and an internationally recognized clinician, researcher, and educator in osteoporosis and metabolic bone diseases. Throughout these episodes, he will speak with two pioneers in the osteoporosis treatment field, Socrates Papapoulos and Felicia Cosman.  These ASBMR members have been critical in harnessing the genetics of high bone mass disorders for their translation i...

Pathways: Stories of Discovery - Dr. Socrates Papapoulos, Leiden University

Our latest series is hosted by Dr. Dolores Shoback, Professor of Medicine at the University of California, San Francisco. Throughout this four part series, we’ll speak with pioneers in the PTH field. We’ll explore basic PTH physiology, actions of PTHrP, PTH for Osteoporosis Treatment and Hypoparathyroidism. The fourth and final episode of this series features Dr. John Bilezikian, Silberberg Professor of Medicine at the Vagelos College of Physicians and Surgeons at Columbia University. John shares his experience in the field, insights into his career, and some pivotal moments along the way.

<description>&lt;p&gt;Our latest series is hosted by Dr. Dolores Shoback, Professor of Medicine at the University of California, San Francisco. Throughout this four part series, we’ll speak with pioneers in the PTH field. We’ll explore basic PTH physiology, actions of PTHrP, PTH for Osteoporosis Treatment and Hypoparathyroidism.&lt;br/&gt;&lt;br/&gt;The fourth and final episode of this series features Dr. John Bilezikian, Silberberg Professor of Medicine at the Vagelos College of Physicians and Surgeons at Columbia University. John shares his experience in the field, insights into his career, and some pivotal moments along the way.&lt;/p&gt;</description>

Our latest series is hosted by Dr. Dolores Shoback, Professor of Medicine at the University of California, San Francisco. Throughout this four part series, we’ll speak with pioneers in the PTH field. We’ll explore basic PTH physiology, actions of PTHrP, PTH for Osteoporosis Treatment and Hypoparathyroidism.  The fourth and final episode of this series features Dr. John Bilezikian, Silberberg Professor of Medicine at the Vagelos College of Physicians and Surgeons at Columbia University. John s...

Pathways: Stories of Discovery - Dr. John Bilezikian, Columbia University

Our latest series is hosted by Dr. Dolores Shoback, Professor of Medicine at the University of California, San Francisco. Throughout this four part series, we’ll speak with pioneers in the PTH field. We’ll explore basic PTH physiology, actions of PTHrP, PTH for Osteoporosis Treatment and Hypoparathyroidism. Episode three features Dr. Benjamin Leder, Professor of Medicine at Harvard University located at Massachusetts General Hospital. Leder shares his beginnings in the field, his experience in clinical research, and much more.

<description>&lt;p&gt;Our latest series is hosted by Dr. Dolores Shoback, Professor of Medicine at the University of California, San Francisco. Throughout this four part series, we’ll speak with pioneers in the PTH field. We’ll explore basic PTH physiology, actions of PTHrP, PTH for Osteoporosis Treatment and Hypoparathyroidism.&lt;br/&gt;&lt;br/&gt;Episode three features Dr. Benjamin Leder, Professor of Medicine at Harvard University located at Massachusetts General Hospital. Leder shares his beginnings in the field, his experience in clinical research, and much more.&lt;/p&gt;</description>

Our latest series is hosted by Dr. Dolores Shoback, Professor of Medicine at the University of California, San Francisco. Throughout this four part series, we’ll speak with pioneers in the PTH field. We’ll explore basic PTH physiology, actions of PTHrP, PTH for Osteoporosis Treatment and Hypoparathyroidism.  Episode three features Dr. Benjamin Leder, Professor of Medicine at Harvard University located at Massachusetts General Hospital. Leder shares his beginnings in the field, his experience ...

Pathways: Stories of Discovery - Dr. Benjamin Leder, Harvard University

Our latest series is hosted by Dr. Dolores Shoback, Professor of Medicine at the University of California, San Francisco. Throughout this four part series, we’ll speak with pioneers in the PTH field. We’ll explore basic PTH physiology, actions of PTHrP, PTH for Osteoporosis Treatment and Hypoparathyroidism. Episode two features guest Dr. Natalie Sims, Deputy Director of St. Vincent&apos;s Institute in Melbourne, Australia and Professorial Fellow at University of Melbourne. In this episode, we&apos;ll explore her experience in research, how data can dictate the direction of a project, advice for early career researchers and more.

<description>&lt;p&gt;Our latest series is hosted by Dr. Dolores Shoback, Professor of Medicine at the University of California, San Francisco. Throughout this four part series, we’ll speak with pioneers in the PTH field. We’ll explore basic PTH physiology, actions of PTHrP, PTH for Osteoporosis Treatment and Hypoparathyroidism.&lt;br/&gt;&lt;br/&gt;Episode two features guest Dr. Natalie Sims, Deputy Director of St. Vincent&amp;apos;s Institute in Melbourne, Australia and Professorial Fellow at University of Melbourne. In this episode, we&amp;apos;ll explore her experience in research, how data can dictate the direction of a project, advice for early career researchers and more.&lt;/p&gt;</description>

Our latest series is hosted by Dr. Dolores Shoback, Professor of Medicine at the University of California, San Francisco. Throughout this four part series, we’ll speak with pioneers in the PTH field. We’ll explore basic PTH physiology, actions of PTHrP, PTH for Osteoporosis Treatment and Hypoparathyroidism.  Episode two features guest Dr. Natalie Sims, Deputy Director of St. Vincent's Institute in Melbourne, Australia and Professorial Fellow at University of Melbourne. In this episode, we'll ...

Pathways: Stories of Discovery - Dr. Natalie Sims, St. Vincent's Institute and University of Melbourne

ASBMR Speaks is the only podcast dedicated to discussing the latest developments in bone, mineral and musculoskeletal research. The American Society for Bone and Mineral Research (ASBMR) is a professional, scientific and medical society established to bring together clinical and experimental scientists who are involved in the study of bone and mineral metabolism.

ASBMR Speaks

Details

Recent Episodes